Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel
Condition(s):Large B-cell Lymphoma; Follicular LymphomaLast Updated:October 19, 2023Available
Hide Studies Not Open or Pending
Condition(s):Large B-cell Lymphoma; Follicular LymphomaLast Updated:October 19, 2023Available
Condition(s):Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Lung NeoplasmsLast Updated:May 14, 2014Completed
Condition(s):Prostate CancerLast Updated:August 28, 2019Completed
Condition(s):Post-ERCP Acute Pancreatitis; Pancreatic Duct Stricture; Pancreatic Duct Stones; Pancreatic Duct LeakageLast Updated:March 21, 2017Completed
Condition(s):HIV-1Last Updated:July 6, 2021Completed
Condition(s):Neoplasms; Advanced Solid Tumors; Non-small Cell Lung Cancer; Colorectal CancerLast Updated:November 6, 2020Completed
Condition(s):Non Small Cell Lung CancerLast Updated:March 15, 2024Recruiting
Condition(s):Locally Advanced Solid TumorLast Updated:January 5, 2024Recruiting
Condition(s):Frontotemporal DementiaLast Updated:July 19, 2023Active, not recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:July 3, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.